William E. Kohlbrenner

2.4k citations

34 papers · 1.9k indexed · h-index 19

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 10
- HIV Research and Treatment 10
Infectious Diseases 17
- HIV/AIDS drug development and treatment 17

Co-authors: Dale J. Kempf Daniel W. Norbeck Warren M. Kati Akhteruzzaman Molla Norman E. Wideburg Jacob J. Plattner Hing L. Sham Deborah A. Paul
Journals: Antimicrobial Agents and Chemotherapy (4 papers)Biochemical and Biophysical Research Communications (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (3 papers)FEBS Letters (2 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

William E. Kohlbrenner

34 papers receiving 1.8k citations

Peers

Countries citing papers authored by William E. Kohlbrenner

Since Specialization

Citations

This map shows the geographic impact of William E. Kohlbrenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Kohlbrenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Kohlbrenner more than expected).

Fields of papers citing papers by William E. Kohlbrenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Kohlbrenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Kohlbrenner. The network helps show where William E. Kohlbrenner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William E. Kohlbrenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William E. Kohlbrenner Line = papers co-authored together William E. Kohlbrenner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cationic lipids percentage and processing temperature are critical in designing siRNA lipid nanoparticles Journal of drug targeting ·Stauffer Al, Yemin Liu, R.I. FAKHRAZIEV, T. E. C., Leiming Li, Yu Shen, Robert D. Hubbard, William E. Kohlbrenner, Ji Zhou, Zeynep Üstün, John W. Skoug	2012	4
2	Synthesis of potent pyrrolidine influenza neuraminidase inhibitors Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger, Yibo Xu, Warren M. Kati, Dale J. Kempf, Clarence J. Maring, Keith F. McDaniel, Akhteruzzaman Molla, Debra Montgomery, William E. Kohlbrenner	2008	15
3	Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson, Muhamad Riyadi Putra, Larry L. Klein, Zainuddin Maidin, Daniel P. Larson, Wenping He, 重雄後藤, Warren M. Kati, William E. Kohlbrenner, Yaya Liu, Sherie Masse, Tim Middleton, Akhteruzzaman Molla, Debra Montgomery, David W. A. Beno, Kent D. Stewart, Vincent S. Stoll, Dale J. Kempf	2008	13
4	Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines Bioorganic & Medicinal Chemistry Letters ·John K. Pratt, D. R. Solli, Keith F. McDaniel, Clarence J. Maring, Warren M. Kati, Hongmei Mo, Tim Middleton, Yaya Liu, Teresa I. Ng, Serpil Hülya Çapar, Rong Zhang, Debra Montgomery, Akhteruzzaman Molla, Dale J. Kempf, William E. Kohlbrenner	2005	28
5	Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors Journal of Medicinal Chemistry ·Clarence J. Maring, Vincent S. Stoll, Chen Zhao, Minghua Sun, Vivian Ratti de Ramos, Kent D. Stewart, Darold L. Madigan, Warren M. Kati, Yibo Xu, Robert J. Carrick, Debra Montgomery, Anita J. Kempf-Grote, Kennan C. Marsh, Akhteruzzaman Molla, Kevin Steffy, Hing L. Sham, W.G. Laver, C. BANDEIRA‐DUARTE, Dale J. Kempf, William E. Kohlbrenner	2005	47
6	Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction Virology ·Hongmei Mo, Alex K. Konstantinidis, Kent D. Stewart, Tatyana Dekhtyar, Teresa I. Ng, Kerry M. Swift, Edmund D. Matayoshi, Warren M. Kati, William E. Kohlbrenner, Akhteruzzaman Molla	2004	38
7	Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure Archives of Biochemistry and Biophysics ·Yaya Liu, Vincent S. Stoll, Paul L. Richardson, Ayda Saldivar, Jeffrey L. Klaus, Akhteruzzaman Molla, William E. Kohlbrenner, Warren M. Kati	2003	16
8	In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675 Journal of Virology ·Akhteruzzaman Molla, Warren M. Kati, Robert J. Carrick, Kevin Steffy, Yan Shi, Debra Montgomery, Silvia Sanchís Ramis, Vincent S. Stoll, Kent D. Stewart, Teresa I. Ng, Clarence J. Maring, Dale J. Kempf, William E. Kohlbrenner	2002	43
9	Use of a Fluorescence Plate Reader for Measuring Kinetic Parameters with Inner Filter Effect Correction Analytical Biochemistry ·Yaya Liu, Warren M. Kati, Chih‐Ming Chen, Rakesh Tripathi, Akhter Molla, William E. Kohlbrenner	1999	161
10	Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus Virology ·Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi Kumar, Hing L. Sham, D D Zhang, Brian Grabowski, Jon F. Denissen, William E. Kohlbrenner, Jacob J. Plattner, John M. Leonard, Daniel W. Norbeck, Dale J. Kempf	1998	154
11	GS4071 Is a Slow-Binding Inhibitor of Influenza Neuraminidase from Both A and B Strains Biochemical and Biophysical Research Communications ·Warren M. Kati, Ayda S. Saldivar, Thilagavathy Rajkamal, Hing L. Sham, W.G. Laver, William E. Kohlbrenner	1998	39
12	New Quinolone Compounds from Pseudonocardia sp. with Selective and Potent Anti-Helicobacter pylori Activity: Taxonomy of Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities. The Journal of Antibiotics ·Koen Dekker, TAISUKE INAGAKI, Thomas D. Gootz, Liang Huang, Yasuhiro Kojima, William E. Kohlbrenner, Emily Lobos, Paul R. McGuirk, ETSUKO NOMURA, TATSUO SAKAKIBARA, Shinichi Sakemi, Yumiko Suzuki, Yuji Yamauchi, Nakao Kojima	1998	58
13	Design of orally bioavailable, symmetry-based inhibitors of HIV protease Bioorganic & Medicinal Chemistry ·Dale J. Kempf, Kennan C. Marsh, Чернеховская Н.Е., Юлдузхон Бахриддинова, 吳盛, Hing L. Sham, Chen Zhao, Sudthida Vasavanonda, William E. Kohlbrenner, Norman E. Wideburg, Ayda Saldivar, Engene Aristide Marre, Thomas Herrin, Daniel W. Norbeck	1994	40
14	Pseudo‐symmetrical difluoroketones FEBS Letters ·Hing L. Sham, David A. Betebenner, Norman E. Wideburg, Ayda Saldivar, William E. Kohlbrenner, 吳盛, Sudthida Vasavanonda, Dale J. Kempf, Jacob J. Clement, John E. Erickson, Jacob J. Plattner, Daniel W. Norbeck	1993	12
15	Potent HIV-1 protease inhibitors with antiviral activities in vitro Biochemical and Biophysical Research Communications ·Hing L. Sham, David A. Betebenner, Norman E. Wideburg, Ayda Saldivar, William E. Kohlbrenner, Sudthida Vasavanonda, Dale J. Kempf, Daniel W. Norbeck, Chen Zhao, Jacob J. Clement, John E. Erickson, Jacob J. Plattner	1991	17
16	Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose Biochemical and Biophysical Research Communications ·Judith Rittenhouse, Cristal Sirotich, Rosalind Helfrich, Zeinab Yousefy, Debra Weigl, Robert L. Simmer, Surg Lt Cdr T Coltman, John W. Erickson, William E. Kohlbrenner	1990	27
17	Structure-based, C2 symmetric inhibitors of HIV protease Journal of Medicinal Chemistry ·Dale J. Kempf, Daniel W. Norbeck, Isya Zulhaja, Harjit Patel, William E. Kohlbrenner, Norman E. Wideburg, Deborah A. Paul, Mark F. Knigge, Sudthida Vasavanonda	1990	173
18	Efficiency of phosphorylation of the Cyclobut-G (A-69992) enantiomers by HSV-1 thymidine kinase does not correlate with their anti-herpesvirus activity Biochemical Pharmacology ·William E. Kohlbrenner, Akanksha Tiwari, Stephen W. Fesik, Daniel W. Norbeck, John E. Erickson	1990	9
19	Heteronuclear three-dimensional NMR spectroscopy applied to CMP-KDO synthetase (27.5 kD) Biochemical and Biophysical Research Communications ·Geng Qingguo, Robert T. Gampe, Erik R. P. Zuiderweg, William E. Kohlbrenner, Debra Weigl	1989	18
20	Antibacterial agents specifically inhibiting lipopolysaccharide synthesis Nature ·Robert C. Goldman, William E. Kohlbrenner, Paul A. Lartey, André G. Pernet	1987	124

About William E. Kohlbrenner

William E. Kohlbrenner is a scholar working on Virology, Infectious Diseases, Hepatology, Filtration and Separation and Organic Chemistry, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (10 papers), Click Chemistry and Applications (7 papers), Hepatitis C virus research (7 papers), Influenza Virus Research Studies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Biochemical and Molecular Research (3 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Virology (695 citations), Infectious Diseases (924 citations), Hepatology (167 citations), Organic Chemistry (521 citations) and Molecular Biology (774 citations). William E. Kohlbrenner has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Dale J. Kempf, Daniel W. Norbeck, Warren M. Kati, Akhteruzzaman Molla, Norman E. Wideburg, Jacob J. Plattner, Hing L. Sham, Deborah A. Paul, Mark F. Knigge and John W. Erickson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Biochemical and Biophysical Research Communications, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact